Literature DB >> 24999246

Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping.

Yonghua Taylor Zhang1, Jennifer Hu2, Amanda L Pace3, Rita Wong3, Y John Wang3, Yung-Hsiang Kao3.   

Abstract

Deamidation is one of the most common degradation pathways for proteins and frequently occurs at "hot spots" with Asn-Gly, Asn-Ser or Asn-Thr sequences. Occasionally, deamidation may occur at other motifs if the local protein structure can participate or assist in the formation of the succinimide intermediate. Here we report the use of a chymotryptic peptide mapping method to identify and characterize a deamidated form of an IgG1 which was observed as an acidic peak in the cation exchange chromatography (CEX). The antibody was formulated in sodium acetate buffer, pH 5.3 and this deamidated form was observed mainly under thermal stress conditions. It was found that the IgG1 molecule with deamidation in the Fc region at asparagine residue 330 (in a Val-Ser-Asn-Lys motif) is the predominant form in this CEX peak, and was missed by tryptic mapping because the peptides are hydrophilic and elute near the void volume. In addition, a domain-based CEX method using papain digestion was developed to monitor the Asn 330 deamidation. These methods revealed that the Fc deamidation occurs mainly at Asn 330 in the VSNK motif at pH 5.3, whereas at pH 7.5, deamidation occurs predominantly at Asn 389 and Asn 394 in the NGQPENNYK motif.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cation exchange chromatography; Deamidation; Digestion strategies; IgG; Peptide mapping

Mesh:

Substances:

Year:  2014        PMID: 24999246     DOI: 10.1016/j.jchromb.2014.06.018

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  9 in total

Review 1.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

Review 2.  Forced degradation of recombinant monoclonal antibodies: A practical guide.

Authors:  Christine Nowak; Jason K Cheung; Shara M Dellatore; Amit Katiyar; Ram Bhat; Joanne Sun; Gomathinayagam Ponniah; Alyssa Neill; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

3.  Characterization and Value Assignment of a Monoclonal Antibody Reference Material, NMIJ RM 6208a, AIST-MAB.

Authors:  Tomoya Kinumi; Kazumi Saikusa; Megumi Kato; Reiko Kojima; Chieko Igarashi; Naohiro Noda; Shinya Honda
Journal:  Front Mol Biosci       Date:  2022-06-06

4.  Identification, Efficacy, and Stability Evaluation of Succinimide Modification With a High Abundance in the Framework Region of Golimumab.

Authors:  Tao Liu; Jin Xu; Qingcheng Guo; Dapeng Zhang; Jun Li; Weizhu Qian; Huaizu Guo; Xinli Zhou; Sheng Hou
Journal:  Front Chem       Date:  2022-04-05       Impact factor: 5.545

5.  Structure Based Prediction of Asparagine Deamidation Propensity in Monoclonal Antibodies.

Authors:  Qingrong Yan; Maggie Huang; Michael J Lewis; Ping Hu
Journal:  MAbs       Date:  2018-07-26       Impact factor: 5.857

6.  Coupling Anion Exchange Chromatography with Native Mass Spectrometry for Charge Heterogeneity Characterization of Monoclonal Antibodies.

Authors:  Anita P Liu; Yuetian Yan; Shunhai Wang; Ning Li
Journal:  Anal Chem       Date:  2022-04-14       Impact factor: 8.008

7.  Improvement of Biophysical Properties and Affinity of a Human Anti-L1CAM Therapeutic Antibody through Antibody Engineering Based on Computational Methods.

Authors:  Heesu Chae; Seulki Cho; Munsik Jeong; Kiyoung Kwon; Dongwook Choi; Jaeyoung Lee; Woosuk Nam; Jisu Hong; Jiwoo Lee; Seonjoo Yoon; Hyojeong Hong
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

8.  Oxidation in the complementarity-determining regions differentially influences the properties of therapeutic antibodies.

Authors:  Tetyana Dashivets; Jan Stracke; Stefan Dengl; Alexander Knaupp; Jan Pollmann; Johannes Buchner; Tilman Schlothauer
Journal:  MAbs       Date:  2016-09-09       Impact factor: 5.857

9.  An explorative study towards the chemical synthesis of the immunoglobulin G1 Fc CH3 domain.

Authors:  Luigi Grassi; Cornelia Roschger; Vesna Stanojlović; Chiara Cabrele
Journal:  J Pept Sci       Date:  2018-10-22       Impact factor: 1.905

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.